idarubicin has been researched along with Adenocarcinoma Of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altman, J; Kuzel, T; Parajuli, R; Perdekamp, M; Tallman, M | 1 |
| Ahmed, T; Budman, D; Scher, HI; Sordillo, P; Watson, RC; Yagoda, A | 1 |
2 other study(ies) available for idarubicin and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Colonic Neoplasms; Colonic Polyps; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Idarubicin; Indoles; Kidney Neoplasms; Leukemia, Promyelocytic, Acute; Lung Neoplasms; Male; Mercaptopurine; Methotrexate; Middle Aged; Neoplasms, Second Primary; Pyrroles; Remission Induction; Sunitinib; Time Factors; Tretinoin | 2010 |
Phase-II trial of 4-demethoxydaunorubicin (DMDR) for advanced hypernephroma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Kidney Neoplasms; Male; Middle Aged | 1985 |